Log In
Print
BCIQ
Print
Print this Print this
 

Cal-1

  Manage Alerts
Collapse Summary General Information
Company Calimmune Inc.
DescriptionAutologous T cell and blood stem cell therapy that blocks CC chemokine receptor 5 (CCR5)
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Stem cell
Latest Stage of DevelopmentPhase I/II
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today